Figure 1.
Some validated molecular targets for AML MRD testing. The frequency and co-occurrence of those molecular targets with evidence of utility for AML MRD testing, based on 200 adult AML patients from the Cancer Genome Atlas database.
Some validated molecular targets for AML MRD testing. The frequency and co-occurrence of those molecular targets with evidence of utility for AML MRD testing, based on 200 adult AML patients from the Cancer Genome Atlas database.